Literature DB >> 1163586

Ocular melanocytosis and melanoma.

F C Blodi.   

Abstract

The hypothesis that ocular melanocytosis is a precancerous condition that may lead to a choroidal melanoma should be seriously questioned for the following reasons: The incidence of malignant degeneration in a hyperpigmented eye is unknown and overreported. If the hypothesis were correct a bilateral melanoma would occasionally occur in patients with bilateral melanosis. No such case has been reported. In patients with unilateral melanosis the blue, unaffected eye may also develop a melanoma. A 67-year-old white woman with one dark and one blue eye provided the first such instance, although previous cases may not have been reported if their histologic picture was not unusual. The incidence of melanoma in our patients with unilateral melanosis was rare compared with the many melanomas developing in normal pigmented eyes (4/418). I found no statistically significant difference in the incidence of choroidal melanomas originating in the hyperpigmented or in the blue eye in patients with unilateral ocular melanocytosis.

Entities:  

Mesh:

Year:  1975        PMID: 1163586     DOI: 10.1016/0002-9394(75)90523-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  An update on ophthalmological perspectives in oculodermal melanocytosis (Nevus of Ota).

Authors:  Solmaz Abdolrahimzadeh; Damiano Maria Pugi; Priscilla Manni; Clemente Maria Iodice; Federico Di Tizio; Flavia Persechino; Gianluca Scuderi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-19       Impact factor: 3.535

2.  A case of melanosis oculi with malignant melanoma of the choroid.

Authors:  A Brini
Journal:  Int Ophthalmol       Date:  1985-03       Impact factor: 2.031

3.  Bilateral ocular melanocytosis with malignant melanoma of the choroid.

Authors:  J R Gonder; J A Shields; J L Shakin; D M Albert
Journal:  Br J Ophthalmol       Date:  1981-12       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.